Nodular lichen myxoedematous: a new adverse event associated with ustekinumab-Reference-Cited by-同舟云学术

Nodular lichen myxoedematous: a new adverse event associated with ustekinumab

Published:2020-04-14 Issue:3 Volume:61 Page:
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Australas J Dermatol

Author:

Montero‐Vilchez Trinidad¹^ORCID,Martinez‐Lopez Antonio¹²^ORCID,Cuenca‐Barrales Carlos³,Martin‐Castro Aurelio⁴,Molina‐Leyva Alejandro¹²^ORCID,Arias‐Santiago Salvador¹²^ORCID

Affiliation:

1. Department of Dermatology at Hospital Universitario Virgen de las Nieves GranadaSpain

2. Instituto de Investigación Biosanitaria ibs.GRANADA GranadaSpain

3. Department of Dermatology at Hospital Universitario San Cecilio GranadaSpain

4. Department of Pathology at Hospital Universitario Virgen de las Nieves Granada Spain

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13291

Reference5 articles.

1. Nodular-Type Lichen Myxedematosus: A Case Report

2. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema

3. Reticular Erythematous Mucinosis Syndrome: Glycosaminoglycan Synthesis by Fibroblasts and Abnormal Response to Interleukin-1β

4. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells

5. Cutaneous mucinosis in a patient taking ustekinumab for palmoplantar psoriasis;Garber C;Dermatol. Online J.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nodular-Type Lichen Myxedematosus: A Rare Variant With Exclusive Involvement of the Hands—Report of Two Cases With a Comprehensive Review of the Literature;The American Journal of Dermatopathology;2024-01

2. Pediatric Lichen Myxedematosus: A Diagnostic and Management Challenge;Children;2022-06-25

3. New and emerging conditions of acquired cutaneous mucinoses in adults;Journal of the European Academy of Dermatology and Venereology;2022-02-17

4. Adult Mucinoses: New and Revisited Variants;New and Emerging Entities in Dermatology and Dermatopathology;2021